The fund is also quite transparent about costs, with a management fee set at 0.80%. When it comes to recent performance, MSOS has posted a return of +35.96% year-to-date, though a longer lens shows a 52-week shift of -26.42%, and the current price is marked at $5.15.

Meanwhile, MSOS remains very actively traded with its volume for the month soaring to 17,361,488, a 128% increase from last month’s 7,610,173. The fund is also options eligible, adding to its trading flexibility.

The most consequential of these is the ongoing federal momentum for cannabis rescheduling, where the U.S. Department of Health and Human Services and the Drug Enforcement Administration are closely involved in shifting marijuana from Schedule I to Schedule III.

This policy movement is crucial, opening the way for lower taxes and streamlined banking, and driving record ETF activity as market participants take positions ahead of the potential change.

Within the sector, companies are taking measurable steps to strengthen their balance sheets and sharpen their strategies. In July, TerrAscend secured a $79 million non-dilutive debt financing package and renewed a $10 million share repurchase program, using available capital not just for survival, but for calculated expansion and ownership consolidation. Meanwhile, Cresco Labs began its planned exit from California operations that same month. This move is part of a broader sector trend where top businesses are pulling back from states with harsh market or regulatory headwinds, redirecting resources for better operational fit and efficiency.

Work on financial stability continues. Glass House Brands finished a preferred equity refinancing round this July, further reinforcing its balance sheet and enabling stable day-to-day operations in a landscape where access to funding can be a decisive factor. On the leadership front, Verano’s president, Darren Weiss, stepped down, a move that fits with larger sector patterns of organizational changes intended to keep companies flexible and aligned with new regulatory and market realities.

Expansion into new markets proceeds at a pace. The Cannabist Company, launched adult-use cannabis sales in Delaware, capturing newly legal demand and broadening its footprint beyond established regions. Trulieve also extended its retail reach, adding a medical cannabis dispensary in Oakland Park, Florida, marking another data point in the push for wider market access and consumer engagement.

All signs point to the cannabis sector finding firmer footing and gaining momentum, with policy shifts and smarter business moves leading the way. Given the ongoing regulatory push and smart decisions from key players, it looks like shares in this space, especially for those tracking top U.S. companies, are poised for further gains rather than sliding back. As long as the news keeps trending positive, more upside than downside seems likely from here.

On the date of publication, Ebube Jones did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Barchart.com